What is Jafron Biomedical Co Price-to-Operating-Cash-Flow?
As of today (2024-05-18), Jafron Biomedical Co's share price is ¥28.93.
Jafron Biomedical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.47. Hence, Jafron Biomedical Co's Price-to-Operating-Cash-Flow Ratio for today is 19.65.
The historical rank and industry rank for Jafron Biomedical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
SZSE:300529'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 14.85 Med: 53.52 Max: 148
Current: 19.65
During the past 13 years, Jafron Biomedical Co's highest Price-to-Operating-Cash-Flow Ratio was 148.00. The lowest was 14.85. And the median was 53.52.
Jafron Biomedical Co's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ¥0.62.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.47.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Jafron Biomedical Co was 19.30% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 0.40% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 18.80% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 25.70% per year.
During the past 13 years, Jafron Biomedical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 47.20% per year. The lowest was -14.60% per year. And the median was 19.10% per year.
Jafron Biomedical Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Jafron Biomedical Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jafron Biomedical Co Price-to-Operating-Cash-Flow Chart
|
Jafron Biomedical Co Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
51.37 |
57.43 |
34.28 |
27.58 |
18.57 |
|
Jafron Biomedical Co Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
24.59 |
21.48 |
19.16 |
18.57 |
15.10 |
Competitive Comparison of Jafron Biomedical Co's Price-to-Operating-Cash-Flow
For the Medical Devices subindustry, Jafron Biomedical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jafron Biomedical Co's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Jafron Biomedical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Jafron Biomedical Co's Price-to-Operating-Cash-Flow falls into.
Jafron Biomedical Co Price-to-Operating-Cash-Flow Calculation
Jafron Biomedical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 28.93 | / | 1.472 |
| = | 19.65 |
Jafron Biomedical Co's Share Price of today is ¥28.93.
Jafron Biomedical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.47.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Jafron Biomedical Co (SZSE:300529) Business Description
Traded in Other Exchanges
N/A
Address
No. 98, Science and Technology 6th Road, High-tech Zone, Guangdong Province, Zhuhai, CHN, 519085
Jafron Biomedical Co Ltd is a China-based company engaged in the research, development, production, and sales of biomaterials and medical devices. It offers solutions for kidney disease, poisoning, rheumatic immune solution, critical illness and liver disease. The company's products include JFYC-100 pre-punching machine, DX-10 blood purifier, and HA resin hemoperfusion.
Jafron Biomedical Co (SZSE:300529) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300529 has been successfully added to your